The composition of proteins in blood changes so dramatically with age that it can accurately predict a person's age. Crucially, these blood-borne factors are not just passive markers; they actively influence how cells and organs function, acting as a form of internal medicine.

By continuously measuring a drug's effect on the body (pharmacodynamics), the wearable device provides a real-time view of a patient's phenotype. This granular data can revolutionize clinical trial design, safety monitoring, and drug dosing, moving beyond static genomic data to understand real-world drug response.

The biohacking movement's focus on interventions like supplements is flawed without first tracking baseline data. To truly "hack" health, one must measure their normal state to see if interventions are effective. Otherwise, it's impossible to know which of the dozens of changes are actually working.

A compelling argument against legalizing PEDs is the "responder vs. non-responder" issue. Since athletes react differently to drugs based on their physiology, victory would depend less on hard work and more on who has the best biological response or the best chemist. This would trigger an endless, dangerous escalation of drug use.

While genomics predicts lifelong risk, Regeneron was surprised to discover that proteomics provides a more powerful, dynamic snapshot of health. In many cases, an individual's proteome was more effective at predicting disease outcomes in the next one to five years than their inherited genome, prompting massive investment in the technology.

The practice of storing athlete samples for 10 years for future retesting acts as a significant deterrent. It removes the finality of "getting away with it," forcing cheaters to live with the constant anxiety that technological advancements could expose them at any moment, tarnishing their legacy long after their victory.

Traditional clinical assessments, like the six-minute walk test, are easily skewed by external factors such as patient fatigue. Effion Health's digital biomarker system can isolate and measure the underlying pathological movement patterns, providing a more sensitive and precise measurement of disease progression regardless of temporary conditions.

Contrary to the belief that athletes are always seeking an edge, USADA CEO Travis Tygart argues the majority are driven by a moral code. The idea of winning illegitimately is antithetical to their self-perception as true competitors, making this internal compass a more powerful deterrent than the fear of being caught.

While mind-reading AI is science fiction, AI that reads your body's telemetry is not. Continuous streams of biological data from wearables and lab tests—like gene expression or white blood cell counts—can act as non-verbal prompts, allowing AI to detect issues like illness before you're consciously aware of them.